PrimeRFP SCOUT · Federal Contract Recompete Brief

HT001422F0059Medical supplies and reagents SUCH as — Roche Diagnostics Corp

Roche Diagnostics Corp holds $245.9M across 1,391 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent HT001421A0001. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Oct 22, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Defense Health Agency

Awarding office

Roche Diagnostics Corp

Recipient

Oct 22, 2022

PoP end

$540K

Obligated

$540K

Potential

622110

NAICS

6515

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Roche Diagnostics Corp — $90

Contract facts

NONE

Contract numberHT001422F0059

Also listed asHT0014-22-F-0059

Also listed asHT001421A0001-HT001422F0059

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentRoche Diagnostics Corp

CAGE51169

UEIJDMDFEZBYH36

NAICS622110

No full NAICS 622110 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDVHT001421A0001

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startFeb 23, 2022

PoP end (current)Oct 22, 2022

Obligated$540K

Current value$540K

Potential value$540K

MEDICAL SUPPLIES AND REAGENTS SUCH AS COBAS OMNI PROCESSING PLATE, KIT COBAS 6800/8800 SPEC DIL REAGENT IVD, KIT COBAS PCR URINE 100 PKT IVD is a federal NONE award for Defense Health Agency held by Roche Diagnostics Corp. Estimated value $540K ($540K obligated). Current period of performance ends Oct 22, 2022. Last award drew 1 bidder. Place of performance: BETHESDA MD.

MEDICAL SUPPLIES AND REAGENTS SUCH AS COBAS OMNI PROCESSING PLATE, KIT COBAS 6800/8800 SPEC DIL REAGENT IVD, KIT COBAS PCR URINE 100 PKT IVD

Recompete timing

Public

● Past PoP end (1399 days ago)

Current PoP ended Oct 22, 2022 (1399 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Roche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($245.9M) · all agencies

Department of Veterans Affairs (VA)$154.1M · 63%Department of Defense (DOD)$77.5M · 32%Department of Health and Human Services (HHS)$10.4M · 4%Department of Justice (DOJ)$3.0M · 1%

Open full company profile →

Related awards

Same parent · incumbent

36C26225N0151

CHEMISTRY IMMUNOASSAY SYSTEM CPT

$5.9M

Aug 31, 2026

36C25025N1021

FSS-BPA ROCHE COBAS 4800 REAGENTS, CONSUMABLES, CONTROLS.

$600K

Aug 31, 2026

FA480321F0055

ROCHE COVID TEST KITS

$159K

Aug 31, 2026

36C25025N1000

COBA REAGENTS/CONSUMABLES

$135K

Aug 31, 2026

36C25726P0473

BENCHMARK ULTRA PLUS

$132K

Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT001422F0059?

HT001422F0059 (Medical supplies and reagents SUCH as) is a Defense Health Agency award with a potential value of $540K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT0014-22-F-0059?

HT0014-22-F-0059 is the dashed form of PIID HT001422F0059 (Medical supplies and reagents SUCH as), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT001422F0059?

Defense Health Agency awarded HT001422F0059 to Roche Diagnostics Corp (potential $540K).

Who is the incumbent on HT001422F0059?

Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Oct 22, 2022.

When does Roche Diagnostics Corp’s HT001422F0059 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 22, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jun 2, 2022